MacroGenics Return on Investment 2012-2025 | MGNX
Current and historical return on investment (ROI) values for MacroGenics (MGNX) over the last 10 years.
| MacroGenics ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $-0.11B | 0.00% | |
| 2025-06-30 | $-0.08B | 0.00% | |
| 2025-03-31 | $-0.10B | 0.00% | |
| 2024-12-31 | $-0.11B | 0.00% | |
| 2024-09-30 | $-0.11B | 0.00% | |
| 2024-06-30 | $-0.20B | 0.00% | |
| 2024-03-31 | $-0.18B | 0.00% | |
| 2023-12-31 | $-0.17B | 0.00% | |
| 2023-09-30 | $-0.11B | 0.00% | |
| 2023-06-30 | $-0.10B | 0.00% | |
| 2023-03-31 | $-0.09B | 0.00% | |
| 2022-12-31 | $-0.12B | 0.00% | |
| 2022-09-30 | $-0.19B | 0.00% | |
| 2022-06-30 | $-0.22B | 0.00% | |
| 2022-03-31 | $-0.22B | 0.00% | |
| 2021-12-31 | $-0.20B | 0.00% | |
| 2021-09-30 | $-0.15B | 0.00% | |
| 2021-06-30 | $-0.13B | 0.00% | |
| 2021-03-31 | $-0.14B | 0.00% | |
| 2020-12-31 | $-0.13B | 0.00% | |
| 2020-09-30 | $-0.17B | 0.00% | |
| 2020-06-30 | $-0.17B | 0.00% | |
| 2020-03-31 | $-0.18B | 0.00% | |
| 2019-12-31 | $-0.18B | 0.00% | |
| 2019-09-30 | $-0.18B | 0.00% | |
| 2019-06-30 | $-0.18B | 0.00% | |
| 2019-03-31 | $-0.17B | 0.00% | |
| 2018-12-31 | $-0.17B | 0.00% | |
| 2018-09-30 | $-0.02B | 0.00% | |
| 2018-06-30 | $-0.04B | 0.00% | |
| 2018-03-31 | $-0.03B | 0.00% | |
| 2017-12-31 | $-0.02B | 0.00% | |
| 2017-09-30 | $-0.16B | 0.00% | |
| 2017-06-30 | $-0.15B | 0.00% | |
| 2017-03-31 | $-0.07B | 0.00% | |
| 2016-12-31 | $-0.06B | 0.00% | |
| 2016-09-30 | $-0.05B | 0.00% | |
| 2016-06-30 | $-0.04B | 0.00% | |
| 2016-03-31 | $-0.10B | 0.00% | |
| 2015-12-31 | $-0.02B | 0.00% | |
| 2015-09-30 | $-0.01B | 0.00% | |
| 2015-06-30 | $0.00B | 0.00% | |
| 2015-03-31 | $0.01B | 0.00% | |
| 2014-12-31 | $-0.04B | 0.00% | |
| 2014-09-30 | $-0.02B | 0.00% | |
| 2014-06-30 | $-0.01B | 0.00% | |
| 2014-03-31 | $0.00B | 0.00% | |
| 2013-12-31 | $0.00B | 0.00% | |
| 2013-06-30 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.111B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |